N. Cos and K. Subbarao, Global epidemiology of influenza: past and present, Annu Rev Med, vol.51, pp.407-421, 2000.

J. Peiris, M. De-jong, and Y. Guan, Avian Influenza Virus (H5N1): a Threat to Human Health, Clinical Microbiology Reviews, vol.20, issue.2, pp.243-267, 2007.
DOI : 10.1128/CMR.00037-06
URL : https://hal.archives-ouvertes.fr/pasteur-00589027

A. Monto and S. Ohmit, Seasonal influenza vaccines: evolutions and future trends, Expert Review of Vaccines, vol.8, issue.4, pp.383-389, 2009.
DOI : 10.1586/erv.09.9

R. Couch, Seasonal inactivated influenza virus vaccines, Vaccine, vol.26, pp.5-9, 2008.
DOI : 10.1016/j.vaccine.2008.05.076

C. Gioia, C. Castilletti, M. Tempestilli, P. Piacentini, and L. Bordi, Cross-subtype Immunity against Avian Influenza in Persons Recently Vaccinated for Influenza, Emerging Infectious Diseases, vol.14, issue.1, pp.121-128, 2008.
DOI : 10.3201/eid1401.061283

J. Tang, L. Karry, and P. Chan, Lack of cross-immune reactivity against influenza H5N1 from seasonal influenza vaccine in humans, Journal of Medical Virology, vol.358, issue.11, pp.1992-1996, 2008.
DOI : 10.1016.jajic.2007.12.007

D. Corti, A. Suguitan, J. Pinna, D. Silacci, C. Fernandez-rodriguez et al., Heterosubtypic neutralizing antibodies are produced by individuals immunized with a seasonal influenza vaccine, Journal of Clinical Investigation, vol.120, issue.5, pp.1663-1673, 2010.
DOI : 10.1172/JCI41902DS1

C. Tsai, C. Caillet, H. Hu, F. Zhou, and H. Ding, Measurement of neutralizing antibody responses against H5N1 clades in immunized mice and ferrets using pseudotypes expressing influenza hemagglutinin and neuraminidase, Vaccine, vol.27, issue.48, pp.6777-6790, 2009.
DOI : 10.1016/j.vaccine.2009.08.056
URL : https://hal.archives-ouvertes.fr/pasteur-00625272

B. Zhou, N. Zhong, and Y. Guan, Treatment with Convalescent Plasma for Influenza A (H5N1) Infection, New England Journal of Medicine, vol.357, issue.14, pp.1450-1451, 2007.
DOI : 10.1056/NEJMc070359

P. Buchy, S. Mardy, S. Vong, T. Toyoda, and J. Aubin, Influenza A/H5N1 virus infection in humans in Cambodia, Journal of Clinical Virology, vol.39, issue.3, pp.164-168, 2007.
DOI : 10.1016/j.jcv.2007.04.010
URL : https://hal.archives-ouvertes.fr/hal-00167807

L. Reed and H. Muench, A simple method of estimating fifty percent endpoints, Am J Hyg, vol.27, pp.493-497, 1938.

R. Zufferey, D. Nagy, R. Mandel, L. Naldini, and D. Trono, Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo, Nature Biotechnology, vol.88, issue.9, pp.871-875, 1997.
DOI : 10.1038/nbt0997-871

L. Naldini, U. Blömer, P. Gallay, D. Ory, and R. Mulligan, In Vivo Gene Delivery and Stable Transduction of Nondividing Cells by a Lentiviral Vector, Science, vol.272, issue.5259, pp.263-267, 1996.
DOI : 10.1126/science.272.5259.263

J. Garcia, S. Pepin, N. Lagarde, E. Ma, and F. Vogel, Heterosubtype Neutralizing Responses to Influenza A (H5N1) Viruses Are Mediated by Antibodies to Virus Haemagglutinin, PLoS ONE, vol.4, issue.11, p.7918, 2009.
DOI : 10.1371/journal.pone.0007918.t001
URL : https://hal.archives-ouvertes.fr/pasteur-00545812

U. Kositanont, P. Wongsurakiat, P. Pooruk, N. Maranetra, and P. Puthavathana, Induction of Cross-Neutralizing Antibody Against H5N1 Virus After Vaccination with Seasonal Influenza Vaccine in COPD Patients, Viral Immunology, vol.23, issue.3, pp.329-334, 2010.
DOI : 10.1089/vim.2009.0082

M. Sandbulte, G. Jimenez, A. Boon, L. Smith, and J. Treanor, Cross-Reactive Neuraminidase Antibodies Afford Partial Protection against H5N1 in Mice and Are Present in Unexposed Humans, PLoS Medicine, vol.41, issue.2, p.59, 2007.
DOI : 10.1371/journal.pmed.0040059.g005

S. Seo and R. Webster, Cross-Reactive, Cell-Mediated Immunity and Protection of Chickens from Lethal H5N1 Influenza Virus Infection in Hong Kong Poultry Markets, Journal of Virology, vol.75, issue.6, pp.2516-2525, 2001.
DOI : 10.1128/JVI.75.6.2516-2525.2001

X. Cheng, M. Eisenbraun, Q. Xu, H. Zhou, and D. Kulkarni, H5N1 Vaccine-Specific B Cell Responses in Ferrets Primed with Live Attenuated Seasonal Influenza Vaccines, PLoS ONE, vol.58, issue.2, p.4436, 2009.
DOI : 10.1371/journal.pone.0004436.t002

M. Alsharifi, Y. Furuya, T. Bowden, M. Lobigs, and A. Koskinen, Intranasal Flu Vaccine Protective against Seasonal and H5N1 Avian Influenza Infections, PLoS ONE, vol.175, issue.4, p.5336, 2009.
DOI : 10.1371/journal.pone.0005336.t001
URL : http://doi.org/10.1371/journal.pone.0005336

T. Ichinohe, S. Tamura, A. Kawaguchi, A. Ninomiya, and M. Imai, Cross???Protection against H5N1 Influenza Virus Infection Is Afforded by Intranasal Inoculation with Seasonal Trivalent Inactivated Influenza Vaccine, The Journal of Infectious Diseases, vol.196, issue.9, pp.1313-1320, 2007.
DOI : 10.1086/521304

J. Kreijtz, R. Bodewes, J. Van-der-brand, G. De-mutsert, and C. Baas, Infection of mice with a human influenza A/H3N2 virus induces protective immunity against lethal infection with influenza A/H5N1 virus, Vaccine, vol.27, issue.36, pp.4983-4989, 2009.
DOI : 10.1016/j.vaccine.2009.05.079

L. Gillim-ross and K. Subbarao, Can Immunity Induced by the Human Influenza Virus N1 Neuraminidase Provide Some Protection from Avian Influenza H5N1 Viruses?, PLoS Medicine, vol.24, issue.2, p.91, 2007.
DOI : 1098-660X(1986)024[0157:SANWAA]2.0.CO;2

A. Van-maurik, N. Sabarth, H. Dacho, P. Brühl, and M. Schwendinger, Seasonal influenza vaccine elicits heterosubtypic immunity against H5N1 that can be further boosted by H5N1 vaccination, Vaccine, vol.28, issue.7, pp.1778-1785, 2010.
DOI : 10.1016/j.vaccine.2009.12.008

T. Tumpey, M. Renshaw, J. Clements, and J. Katz, Mucosal Delivery of Inactivated Influenza Vaccine Induces B-Cell-Dependent Heterosubtypic Cross-Protection against Lethal Influenza A H5N1 Virus Infection, Journal of Virology, vol.75, issue.11, pp.5141-5150, 2001.
DOI : 10.1128/JVI.75.11.5141-5150.2001

W. Biddison, S. Shaw, and D. Nelson, Virus specificity of human influenza virusimmune cytotoxic T cells, J Immunol, vol.122, pp.660-664, 1979.

A. Boon, G. De-mutsert, D. Van-baarle, D. Smith, and A. Lapedes, Recognition of Homo- and Heterosubtypic Variants of Influenza A Viruses by Human CD8+ T Lymphocytes, The Journal of Immunology, vol.172, issue.4, pp.2453-2460, 2004.
DOI : 10.4049/jimmunol.172.4.2453

L. Lee, D. Ha, C. Simmons, M. De-jong, and N. Chau, Memory T cells established by seasonal human influenza A infection cross-react with avian influenza A (H5N1) in healthy individuals, J Clin Invest, vol.118, pp.3478-3490, 2008.

H. Bui, B. Peters, E. Assarsson, I. Mbawuike, and A. Sette, Ab and T cell epitopes of influenza A virus, knowledge and opportunities, Proceedings of the National Academy of Sciences, vol.104, issue.1, pp.246-251, 2007.
DOI : 10.1073/pnas.0609330104

J. Jameson, J. Cruz, and F. Ennis, Human cytotoxic T-lymphocyte repertoire to influenza A viruses, J Virol, vol.72, pp.8682-8689, 1998.

A. Mcmichael and B. Askonas, Influenza virus-specific cytotoxic T cells in man; induction and properties of the cytotoxic cell, European Journal of Immunology, vol.7, issue.10, pp.705-711, 1878.
DOI : 10.1002/eji.1830081007